Michael Joseph Rybak

Michael Joseph Rybak is a Professor in the Department of Pharmacy Practice at Wayne State University's Eugene Applebaum College of Pharmacy & Health Sciences. He is an internationally recognized expert in antimicrobial pharmacokinetics/pharmacodynamics and infectious diseases outcomes research.

• Degrees: Ph.D. (Public Health, Walden University), M.P.H. (Wayne State University), Pharm.D. (Wayne State University), B.S. (Northeastern University)
• Certifications: Board Certified Pharmacotherapy Specialist, Added Qualifications in Infectious Diseases Pharmacotherapy

Dr. Rybak's research focuses on optimizing antimicrobial therapies against resistant pathogens, particularly MRSA, vancomycin-resistant Enterococcus, and gram-negative bacteria. His work spans PK/PD modeling, clinical outcomes assessment, and phage-antibiotic synergy studies.

Recent publications highlight his contributions to combination therapies for multidrug-resistant organisms, including studies on phage-antibiotic interactions, beta-lactamase inhibitors, and novel agents like sulbactam-durlobactam. His research has been presented at major conferences including ESCMID 2025.

• Awards: Distinguished Investigator Awards, Fellow Recognition Awards (ACCP, SIDP), Career Chair Development Award, Therapeutics Frontiers Lecture Award
• Professional Memberships: Infectious Diseases Society of America, American College of Clinical Pharmacy, European Society of Clinical Microbiology & Infectious Diseases, and 12+ other societies

He directs the Anti-Infective Research Laboratory at Wayne State University and serves as an adjunct professor of medicine. His work informs clinical guidelines for treating resistant infections in critical care settings.